by Benzinga Insights | Jan 9, 2026 | General
Revolution Medicines (NASDAQ:RVMD) has outperformed the market over the past 5 years by 13.22% on an annualized basis producing an average annual return of 26.1%. Currently, Revolution Medicines has a market capitalization of $22.91 billion. Buying $100 In RVMD: If an...
by Benzinga Insights | Jan 9, 2026 | General
Agnico Eagle Mines (NYSE:AEM) has outperformed the market over the past 5 years by 9.22% on an annualized basis producing an average annual return of 22.1%. Currently, Agnico Eagle Mines has a market capitalization of $95.24 billion. Buying $100 In AEM: If an investor...
by Benzinga Insights | Jan 9, 2026 | General
Enphase Energy (NASDAQ:ENPH) has outperformed the market over the past 10 years by 17.37% on an annualized basis producing an average annual return of 31.09%. Currently, Enphase Energy has a market capitalization of $4.62 billion. Buying $1000 In ENPH: If an investor...
by Benzinga Insights | Jan 9, 2026 | General
e.l.f. Beauty (NYSE:ELF) has outperformed the market over the past 5 years by 17.57% on an annualized basis producing an average annual return of 30.44%. Currently, e.l.f. Beauty has a market capitalization of $5.18 billion. Buying $100 In ELF: If an investor had...
by Benzinga Insights | Jan 9, 2026 | General
Nucor (NYSE:NUE) has outperformed the market over the past 10 years by 2.57% on an annualized basis producing an average annual return of 16.29%. Currently, Nucor has a market capitalization of $37.94 billion. Buying $1000 In NUE: If an investor had bought $1000 of...
Recent Comments